iSpecimen Inc. (ISPC) Tops Q2 EPS by 9c

iSpecimen Inc. (NASDAQ: ISPC) reported Q2 EPS of ($0.19), $0.09 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $2.86 million versus the consensus estimate of $2.88 million.

For earnings history and earnings-related data on iSpecimen Inc. (ISPC) click here.

You May Also Be Interested In

• Mizuho Upgrades Five Below (FIVE) to Outperform, 'we believe the pendulum has swung too far on valuation'
• Oil's H2 track record: 60% win rate masks midterm-year drag
• Wolfe Research Downgrades Arthur J. Gallagher (AJG) to Peerperform